A multianalyte assay panel with cell-bound complement activation products demonstrates clinical utility in systemic lupus erythematosus

A multianalyte assay panel with cell-bound complement activation products demonstrates clinical utility in systemic lupus erythematosus

Objective To evaluate the clinical utility of the multianalyte assay panel (MAP), commercially known as AVISE Lupus test (Exagen Inc.), in patients suspected of SLE.Methods A systematic review of medical records of ANA-positive patients with a positive (>0.1) or negative (<−0.1) MAP sc...

Full description

Bibliographic Details
Main Authors: John Conklin, Vinicius Domingues, Roberta Vezza Alexander, Arthur Weinstein, Mansoor Ahmed, Daniel Scott Rey, Jazibeh Qureshi
Format: Article
Language:English
Published: BMJ Publishing Group 2021-07-01
Series:Lupus Science and Medicine
Online Access:https://lupus.bmj.com/content/8/1/e000528.full

Internet

https://lupus.bmj.com/content/8/1/e000528.full

Similar Items